Occult Blood

Download PDF

Recent Publications on Occult Blood:
The Impact of Consumer-Directed Health Plans and Patient Socioeconomic Status on Physician Recommendations for Colorectal Cancer Screening. BACKGROUND: Consumer-directed health plans are increasingly common, yet...	17th July, 2008	The Robert Wood Johnson Clinical Scholars Program, University of	J Gen Intern Med. 2008 Jul 16;. DOI Direct Link
Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. AIMS: Objective of this study was to compare the assay characteristics of...	17th July, 2008	Department of Nutritional Medicine (180), University of Hohenheim,	Int J Colorectal Dis. 2008 Jul 16;. DOI Direct Link
Fecal DNA screening in colorectal cancer. Colorectal cancer (CRC) is the third most common type of cancer diagnosed...	17th July, 2008	University of Western Ontario, London, Canada.	Can J Gastroenterol. 2008 Jul;22(7):631-3.
Wait time for endoscopic evaluation at a Canadian tertiary care centre: Comparison with Canadian Association of Gastroenterology targets. Background: In recent years, there has been considerable concern regarding...	17th July, 2008	Kingston General Hospital, Queen's University, Kingston, Canada.	Can J Gastroenterol. 2008 Jul;22(7):621-6.
Colorectal cancer test use from the 2005 national health interview survey. BACKGROUND: Screening is effective in reducing colorectal cancer...	17th July, 2008	Division of Cancer Prevention and Control, Centers for Disease Control and	Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623-30. DOI Direct Link
→View more research publications.

BioNews Results for Occult Blood:
Clinical Trial Update	Retinal Physician:  Jul 18 2008 5:00PM Matching: occult blood
US colorectal cancer screening rates still too low	Cancer.net:  Jul 17 2008 6:44AM Matching: occult blood
US colorectal cancer screening rates still too low	Reuters Health:  Jul 16 2008 9:33PM Matching: occult blood
Colon cancer screening rates still too low	National Post:  Jul 16 2008 7:25PM Matching: occult blood
Colon cancer screening rates still too low	Reuters UK:  Jul 16 2008 4:36PM Matching: occult blood
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Occult Blood Clinical Trials:
Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer	Colorectal Cancer

Occult Blood Patents:
US Patent No.	Title
7189823	Antibody against illfdyfnr
7238538	Chromatographic assay device and methods
7252955	Method of detecting colon cancer
7253143	Peptides based on the sequence of human lactoferrin and their use
7254503	Light source wavelength correction
→View more patents.

Companies working in the area of Occult Blood from Bioportfolio's Biocorporate database :
Company Name
Epitope Diagnostics, Inc. Epitope Diagnostics will launch its innovative fecal sample-based rapid immunoassy test platform during the AACC meeting. This novel fecal sample test system is so user-friendly that it protects both... www.epitopediagnostics.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Occult Blood scientists - we have details of around 433 individuals working on Occult Blood .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.